First AD

Second AD

Myeloproliferative Neoplasms

INC-22-OSD1258 - /clinical/myeloproliferative-neoplasms

The OncLive Myeloproliferative Neoplasms condition center is a comprehensive resource for clinical news and expert insights on myeloproliferative neoplasms, including myelofibrosis, polycythemia vera, and essential thrombocythemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in myeloproliferative neoplasms.

Inside the Clinic: Myeloproliferative Neoplasms: Current and Future Standards of Care 

Insights

A comprehensive review of novel agents currently under investigation with a potential role in the myelofibrosis treatment landscape.

Novel Agents in the Pipeline for Myelofibrosis

A Brief Overview of Myeloproliferative Neoplasms

Making a Differential Diagnosis of Polycythemia Vera

Treatment Armamentarium for Polycythemia Vera

Polycythemia Vera: Ruxolitinib Use and Goals of Therapy 

Making a Differential Diagnosis of Myelofibrosis 

Addressing the Challenges in Diagnosing MF

Risk Assessment and Staging of Myelofibrosis 

Myelofibrosis: Observation and Triggers to Initiate Therapy

Factors in Selecting Therapy for Myelofibrosis 

Historical Approaches to the Management of MF

Use of Ruxolitinib in Myelofibrosis 

Myelofibrosis: Use of Fedratinib and Pacritinib Therapy

Selection and Management of JAK Inhibitor Therapy in MF  

Myelofibrosis: Patient Monitoring and Triggers to Change Therapy 

Myelofibrosis: Novel Combination Strategies 

Clinical Pearls for the Management of Myelofibrosis 